| Literature DB >> 20435137 |
Laura S Steffens1, Samantha Nicholson, Lynthia V Paul, Carl Erik Nord, Sheila Patrick, Valerie R Abratt.
Abstract
Bacteroides fragilis is a human gut commensal and an opportunistic pathogen causing anaerobic abscesses and bacteraemias which are treated with metronidazole (Mtz), a DNA damaging agent. This study examined the role of the DNA repair protein, RecA, in maintaining endogenous DNA stability and its contribution to resistance to Mtz and other DNA damaging agents. RT-PCR of B. fragilis genomic DNA showed that the recA gene was co-transcribed as an operon together with two upstream genes, putatively involved in repairing oxygen damage. A B. fragilis recA mutant was generated using targeted gene inactivation. Fluorescence microscopy using DAPI staining revealed increased numbers of mutant cells with reduced intact double-stranded DNA. Alkaline gel electrophoresis of the recA mutant DNA showed increased amounts of strand breaks under normal growth conditions, and the recA mutant also showed less spontaneous mutagenesis relative to the wild type strain. The recA mutant was sensitive to Mtz, ultraviolet light and hydrogen peroxide. A B. fragilis strain overexpressing the RecA protein exhibited increased resistance to Mtz compared to the wild type. This is the first study to show that overexpression of a DNA repair protein in B. fragilis increases Mtz resistance. This represents a novel drug resistance mechanism in this bacterium. 2010 Elsevier Masson SAS. All rights reserved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20435137 PMCID: PMC3025348 DOI: 10.1016/j.resmic.2010.04.003
Source DB: PubMed Journal: Res Microbiol ISSN: 0923-2508 Impact factor: 3.992
Bacterial strains and plasmids.
| Strain/plasmid | Relevant characteristics or use | Source/reference |
|---|---|---|
| Multiple sequence alignment | ||
| Multiple Sequence alignment | ||
| Multiple sequence alignment | ||
| Multiple sequence alignment | ||
| Multiple sequence alignment | ||
| Multiple sequence alignment | ||
| Multiple sequence alignment | ||
| 638R | Clinical strain, RifRGentR | |
| 638R | 638R derivative, | This study |
| 638R (pLYL01) | 638R RifRGentRTetR | This study |
| 638R | 638R | This study |
| 638R | 638R | This study |
| 638R (pLYLrecA) | 638R ( | This study |
| S17-1 | RP4-2-Tc::Mu | |
| S17-1 (pGREC) | S17-1 containing pGREC | This study |
| S17-1 (pLYL01) | S17-1 containing pLYL01 | This study |
| S17-1 (pLYLrecA) | S17-1 containing pLYLrecA | This study |
| Plasmids | ||
| pGERM | pUC19-based suicide vector, ErmR | |
| pGREC | pGERM containing | This study |
| pLYL01 | Mob+, TetRAmpR | |
| pLYLrecA | pLYL01 containing | This study |
Rif, rifampicin; Gent, gentamicin; Erm, erythromycin; Tet, tetracycline; Strep, streptomycin; Amp, ampicillin; Mob, mobilisation; R, resistant; S, sensitive.
Consensus sequences for regions of functional importance in the RecA protein.
| Walker A | GPESSGKTT | |
| Walker B | IVVD | |
| L1/L2 | EGDMGD FINQLREKIGVMFGNPETTTGGNALKFY | |
| Glutamate (E) | IDAEHA | |
| Glutamine (Q) | FINQL |
Primers used.
| Name | Primer | Description | Reference |
|---|---|---|---|
| FRA | 5′-GTA AAG CTG CAG ATG AAG TGA TCG-3′ ( | FRA and RRA amplify the full-length | This study |
| RRA | 5′-GGG CAT GCC TAT CGA GTT GG-3′ ( | This study | |
| FBRT | 5′-CCG GCT ATG ATC GGT GCC-3′ | FBRT and RBRT amplify the intergenic region between BF638R1248 and BF638R1246/7. | This study |
| RBRT | 5′-CGG CTT TAC GTA GCT CTG CG-3′ | This study | |
| RART | 5′-CGT GGA TGG CCA GTG TCG-3′ | FRA and RART amplify the intergenic region between BF638R1246/7 and BF638R1245. | This study |
| M13F | 5′-CGC CAG GGT TTT CCC AGT CAC GAC-3′ | M13F and M13R in combination with gene-specific primers allow verification of mutation in | |
| M13R | 5′-GAG CGG ATA ACA ATT TCA CAC AGG-3′ | ||
| RIF | 5′-CAG GTT CGA TAG CAC TGA ATG C-3′ | RIF and RIR amplify an internal fragment of the | This study |
| RIR | 5′-CGG ATT ACC GAA CAT TAC ACC G-3′ | This study |
Fig. 1(a) Genetic context of B. fragilis 638R recA and RT-PCR primer combinations. The primers shown above are fully described in Table 3. Grey arrows, primers amplifying intergenic regions. (b) RT-PCR of intergenic regions indicated, using RNA extracted from B. fragilis 638R. Lane 1, Molecular size marker (λ DNA digested with PstI); lanes 4 & 7, no DNA template control; lanes 2 & 5, cDNA; lanes 3 & 6, genomic DNA.
Fig. 2Determination of DNA breaks. (a) Alkaline denaturing agarose gel electrophoresis (0.5%) of B. fragilis 638R (lane 1) and the recA mutant (lane 2). (b) Agarose gel electrophoresis (0.8%) of lane 1, molecular size marker (λ DNA digested with PstI); B. fragilis 638R (lane 2) and recA mutant (lane 3).
Fig. 3Survival curves of the B. fragilis strains in response to DNA damage with (a) UV, (b) Mtz and (c) hydrogen peroxide. Filled circles, B. fragilis 638R(pLYL01); filled squares, B. fragilis 638R recA mutant(pLYL01); filled triangles, B. fragilis 638R recA mutant complemented with pLYLrecA; filled diamonds, B. fragilis 638R recA overexpressor (pLYLrecA). The errors bars represent the standard error calculated from at least three replicates of data.
Mtz susceptibility (MIC) of the B. fragilis strains.
| Strain | MIC (mg/L) |
|---|---|
| 638R | 0.125 |
| 638R (pLYL01) | 0.125 |
| 638R | 0.016 |
| 638R | 0.016 |
| 638R | 0.094 |
| 638R (pLYLrecA) | 0.125 |